Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Assets (2016 - 2025)

Historic Assets for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $21.8 million.

  • Lisata Therapeutics' Assets fell 4303.78% to $21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.8 million, marking a year-over-year decrease of 4303.78%. This contributed to the annual value of $35.0 million for FY2024, which is 3600.39% down from last year.
  • As of Q3 2025, Lisata Therapeutics' Assets stood at $21.8 million, which was down 4303.78% from $25.2 million recorded in Q2 2025.
  • Over the past 5 years, Lisata Therapeutics' Assets peaked at $66.3 million during Q1 2023, and registered a low of $21.8 million during Q3 2025.
  • Its 3-year average for Assets is $43.8 million, with a median of $42.6 million in 2024.
  • In the last 5 years, Lisata Therapeutics' Assets tumbled by 2726.83% in 2024 and then plummeted by 4303.78% in 2025.
  • Quarter analysis of 3 years shows Lisata Therapeutics' Assets stood at $54.7 million in 2023, then plummeted by 36.0% to $35.0 million in 2024, then tumbled by 37.83% to $21.8 million in 2025.
  • Its last three reported values are $21.8 million in Q3 2025, $25.2 million for Q2 2025, and $29.0 million during Q1 2025.